Search Within

Joachim Yahalom

  1. "Blood"
Formats
  1. Meeting Abstract (80)
  2. Journal Article (15)
  3. Guidelines (1)
Groups
  1. Radiation Oncology, Department of (96)
  2. Survivorship Research (96)
  3. Department of Medicine (81)
  4. Hematologic Malignancies, Division of (80)
  5. Center for Hematologic Malignancies (77)
  6. Lymphoma (65)

More Groups

People
  1. Andrew Zelenetz (49)
  2. Craig Moskowitz (37)
  3. Ariela Noy (31)
  4. David Straus (31)
  5. Brandon Imber (29)
  6. Maria Palomba (25)

More People

Years
  1. 2024 (4)
  2. 2023 (12)
  3. 2022 (9)
  4. 2021 (8)
  5. 2020 (4)
  6. 2019 (9)

More Years

Publications
  1. Blood (96)
Publishers
  1. American Society of Hematology (96)

Results (96)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A pilot study of brentuximab vedotin combined with AVD chemotherapy and radiotherapy in patients with newly diagnosed early stage, unfavorable risk Hodgkin lymphoma
    Meeting Abstract

    Kumar, A.; Casulo, C.; Advani, R. H.; Budde, L. E.; Barr, P. M.; Batlevi, C. L.; Caron, P.; Constine, L. S.; Dandapani, S.; Drill, E.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Early experience using radiotherapy as a salvage treatment for relapsed or refractory non-Hodgkin lymphomas following CD19 chimeric antigen receptor modified T-cell therapy
    Meeting Abstract

    Imber, B.; Palomba, M. L.; DeSelm, C.; Dahi, P. B.; Sauter, C. S.; Scordo, M.; Batlevi, C. L.; Park, J. H.; Shah, G. L.; Giralt, S. A.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • MSKCC early experience using radiotherapy as a bridging strategy for relapsed diffuse large B cell lymphoma before CD19 CAR T therapy
    Meeting Abstract

    Imber, B.; Palomba, M. L.; DeSelm, C.; Batlevi, C. L.; Dahi, P. B.; Giralt, S. A.; Noy, A.; Park, J. H.; Sauter, C. S.; Scordo, M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Should a bulky mediastinal mass ≥7cm in the longest dimension be considered an adverse prognostic factor in patients with advanced Hodgkin lymphoma and negative interim PET/CT?
    Meeting Abstract

    Dann, E. J.; Lopez-Alonso, R.; Qi, S.; Mashiach, T.; Weiler-Sagie, M.; Yahalom, J.
    Blood (2019)

    Fulltext@MSK | Save
  • Outcomes of 210 patients with follicular and marginal zone lymphomas treated with 4 Gy of radiation therapy
    Meeting Abstract

    Chau, K.; Imber, B.; Joffe, E.; Yang, J. C.; Chelius, M.; Doyle, C.; Hajj, C.; Yahalom, J.
    Blood (2019)

    Fulltext@MSK | Save
  • Definitive radiotherapy for localized follicular lymphoma staged by (18)F-FDG PET-CT: A collaborative study by ILROG
    Journal Article

    Brady, J. L.; Binkley, M. S.; Hajj, C.; Chelius, M.; Chau, K.; Balogh, A.; Levis, M.; Filippi, A. R.; Jones, M.; Manus, M. M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Proton therapy for adults with mediastinal lymphomas: The International Lymphoma Radiation Oncology Group guidelines
    Journal Article

    Dabaja, B. S.; Hoppe, B. S.; Plastaras, J. P.; Newhauser, W.; Rosolova, K.; Flampouri, S.; Mohan, R.; Mikhaeel, N. G.; Kirova, Y.; Specht, L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • A pilot study of brentuximab vedotin and AVD chemotherapy followed by 20 Gy involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma
    Meeting Abstract

    Kumar, A.; Casulo, C.; Advani, R. H.; Budde, L.; Barr, P. M.; Batlevi, C. L.; Caron, P.; Chen, R. W.; Constine, L. S.; Courtien, A.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphoma
    Journal Article

    Moskowitz, A. J.; Schöder, H.; Gavane, S.; Thoren, K. L.; Fleisher, M.; Yahalom, J.; McCall, S. J.; Cadzin, B. R.; Fox, S. Y.; Gerecitano, J.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Curative radiation for orbital MZL: How much?
    Journal Article

    Yahalom, J.
    Blood (2017)

    Fulltext@MSK | Save